Resources

Accelerating viral vectors commercialization to market through suspension platform with greater predictability

Abstract: Developing innovative advanced therapies is one of our greatest opportunities to dramatically improve patients’ lives. In this webinar, we will discuss our recent technical advancement on efficient viral vector manufacturing process development. From cell line development, suspension culture of HEK293 cells, transfection, to cell culture optimization and purification process development, a series of progress …Read More >

Resource Type: Webinar
Resource Topic: Clinical & Commercial Manufacturing

VIEW

Accelerating viral vectors commercialization through AAV suspension platform

  Summary of the Presentation given at Phacilitate in Miami (2020): – Established suspension HEK293 cell line – In-stock raw materials with established batch records – State-of-the-art GMP manufacturing facilities with enhanced scalability that range up to 1000L – Established and dedicated process & analytical development teams – Strong and dedicated technical guidance including regulatory …Read More >

Resource Type: Presentation
Resource Topic: Clinical & Commercial Manufacturing

VIEW

Phacilitate poster 2 – Downstream development challenges and progress for AAVs

From clarification to separation of empty and full capsids, each downstream processing step has its challenges in viral vector manufacturing at a CDMO.

Resource Type: Poster
Resource Topic: Clinical & Commercial Manufacturing

VIEW

Phacilitate poster 1 – Accelerating development and manufacturing platform for viral vector

In this poster, we will discuss our recent technical advancement on efficient viral vector manufacturing process development.

Resource Type: Poster
Resource Topic: Clinical & Commercial Manufacturing

VIEW

BIO 2019 recognizes WuXi AppTec

WuXi AppTec’s enabling capabilities and contribution to the development of life science were recognized by both its many partners and the City of Philadelphia at the BIO International Convention 2019. The BIO International Convention is hosted annually by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers …Read More >

Resource Type: Article
Resource Topic: Advanced Testing Clinical & Commercial Manufacturing

VIEW